Pathogenesis of HIV-associated heart disease

被引:38
作者
Barbaro, G [1 ]
机构
[1] Univ Roma La Sapienza, Dept Med Pathophysiol, Rome, Italy
关键词
HIV; AIDS; autoimmunity; chemokines; cytokines; cardiomyopathy; cardiovascular disease; highly active antiretroviral therapy;
D O I
10.1097/00002030-200304001-00003
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
As longevity increases in HIV-infected individuals after the introduction of highly active antiretroviral therapy regimens, long-term effects such as cardiovascular disease and, more specifically, symptomatic heart failure are emerging as leading health issues. In the present review article, we discuss HIV-associated cardiovascular disease, focusing on etiopathogenetic mechanisms that may play a role in diagnosis, management, and therapy of HIV-associated heart failure in the highly active antiretroviral therapy era. (C) 2003 Lippincott Williams Wilkins.
引用
收藏
页码:S12 / S20
页数:9
相关论文
共 60 条
[1]   Hypertension in the HIV-infected patient [J].
Aoun S. ;
Ramos E. .
Current Hypertension Reports, 2000, 2 (5) :478-481
[2]   AMPHOTERICIN B-INDUCED DILATED CARDIOMYOPATHY [J].
ARSURA, EL ;
ISMAIL, Y ;
FREEDMAN, S ;
KARUNAKAR, ARSR .
AMERICAN JOURNAL OF MEDICINE, 1994, 97 (06) :560-562
[3]   Cardiac involvement in the acquired immunodeficiency syndrome: A multicenter clinical-pathological study [J].
Barbaro, G ;
Di Lorenzo, G ;
Grisorio, B ;
Barbarini, G .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1998, 14 (12) :1071-1077
[4]  
Barbaro G, 2001, Lancet Infect Dis, V1, P115, DOI 10.1016/S1473-3099(01)00067-6
[5]   Cardiovascular manifestations of HIV infection [J].
Barbaro, G .
CIRCULATION, 2002, 106 (11) :1420-1425
[6]   The expanding role of the cardiologist in the care of HIV infected patients [J].
Barbaro, G ;
Fisher, SD ;
Pellicelli, AM ;
Lipshultz, SE .
HEART, 2001, 86 (04) :365-367
[7]   Cardiovascular manifestations of HIV infection [J].
Barbaro, G .
JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 2001, 94 (08) :384-390
[8]   RETRACTED: Clinical course of cardiomyopathy in HIV-infected patients with or without encephalopathy related to the myocardial expression of tumour necrosis factor-α and nitric oxide synthase (Retracted Article. See vol 18, pg 1087, 2004) [J].
Barbaro, G ;
Di Lorenzo, G ;
Soldini, M ;
Giancaspro, G ;
Grisorio, B ;
Pellicelli, AM ;
D'Amati, G ;
Barbarini, G .
AIDS, 2000, 14 (07) :827-838
[9]   Intensity of myocardial expression of inducible nitric oxide synthase influences the clinical course of human immunodeficiency virus-associated cardiomyopathy [J].
Barbaro, G ;
Di Lorenzo, G ;
Soldini, M ;
Giancaspro, G ;
Grisorio, B ;
Pellicelli, A ;
Barbarini, G .
CIRCULATION, 1999, 100 (09) :933-939
[10]  
Behrens G, 1998, LANCET, V351, P1958, DOI 10.1016/S0140-6736(98)26026-0